Steven George Hughes

This profile gathers the share dealings of Steven George Hughes across 2 companies, led by Avidity Biosciences, Inc. and Atrium Therapeutics, Inc. We count 15 filings; the first trade dates from 6 January 2025 and the latest from 18 September 2026.

Sales make up the whole of the open-market record (5 sales, €672k). The rest of the record consists of 3 share grants and 6 option exercises. In 2026 alone, the filings show no purchases and 2 sales.

The record was last updated on 22 September 2026 with a share grant (€167k) in Atrium Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.